Core Insights - OneSpaWorld reported record financial results for the third quarter of fiscal 2025, with total revenues of $258.5 million, net income of $24.3 million, and adjusted EBITDA of $35.0 million, marking the 18th consecutive quarter of year-over-year growth in these metrics [1][2][4]. Financial Performance - Total revenues increased by 7% compared to the third quarter of 2024, driven by a 4% rise in average guest spend, fleet expansion from new ship builds, and a 1% increase in revenue days [7][8]. - Net income rose by 13% to $24.3 million, with adjusted net income reaching $30.4 million, reflecting a 11% increase year-over-year [17][31]. - Adjusted EBITDA increased by 6% to $35.0 million compared to the same quarter last year [7][31]. Operational Highlights - The company ended the quarter with health and wellness centers on 204 ships, an increase from 196 ships in the previous year, and 49 destination resort health and wellness centers [7][20]. - The average ship count for the quarter was 199, up from 195 in the third quarter of 2024 [21]. - The company launched wellness centers on four new ship builds during the quarter and plans to launch additional centers on two more ships by year-end [2][3]. Capital Allocation and Shareholder Returns - OneSpaWorld returned $4.1 million to shareholders through dividends and repurchased $17.6 million worth of shares during the quarter [3][12]. - The board approved a 25% increase in the quarterly dividend to $0.05 per share, payable on December 3, 2025 [11][12]. - The company ended the quarter with $30.8 million in cash and total liquidity of $80.8 million, positioning it well for future growth [5][17]. Guidance and Outlook - The company expects total revenues for fiscal 2025 to increase by 8% and adjusted EBITDA to rise by 10% at the mid-point of guidance ranges compared to fiscal 2024 results [3][10].

Company Overview - Hims & Hers Health, Inc is a telehealth platform that provides a variety of health and wellness services, connecting consumers with healthcare professionals [1] - The company offers tailored prescriptions, non-prescription products, and additional services [1] Analyst Background - The analysis is conducted by a qualified accountant with extensive experience in financial services, including private equity, hedge funds, asset management, and venture capital [1] - The analyst has developed skills in financial analysis, risk assessment, and identifying investment opportunities across various companies [1] Disclosure Information - The analyst has no current stock, option, or similar derivative positions in any of the companies mentioned and does not plan to initiate any such positions within the next 72 hours [1] - The article reflects the analyst's personal opinions and is not compensated by any company mentioned [1]